<?xml version="1.0" encoding="UTF-8"?><!--EDGARizerX:  Instance document generated by EDGARizerX, version 3.1.1.0--><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:asi="http://frx.com/20090810" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://xbrl.us/us-gaap/2008-03-31" xmlns:frx="http://frx.com/20090630" xmlns:dei="http://xbrl.us/dei/2008-03-31">
  <link:schemaRef xlink:type="simple" xlink:href="frx-20090630.xsd"/>
  <context id="c00000">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <instant>2008-03-31</instant>
    </period>
  </context>
  <context id="c00001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <instant>2008-06-30</instant>
    </period>
  </context>
  <context id="c00002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="c00003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <instant>2009-03-31</instant>
    </period>
  </context>
  <context id="c00004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <instant>2009-06-30</instant>
    </period>
  </context>
  <context id="c00005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <startDate>2009-04-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="c00006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="c00007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000038074</identifier>
    </entity>
    <period>
      <startDate>2009-03-31</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <unit id="u000">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="u001">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="u002">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <!--Deferred income tax benefit-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="u000" decimals="-3" contextRef="c00005">-7679000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Deferred income tax benefit-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="u000" decimals="-3" contextRef="c00006">-3073000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="u001" decimals="0" contextRef="c00005">303393</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Diluted (in shares)-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="u001" decimals="0" contextRef="c00006">308329</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareDiluted unitRef="u002" decimals="-2" contextRef="c00005">0.87</us-gaap:EarningsPerShareDiluted>
  <!--Diluted (in dollars per share)-->
  <us-gaap:EarningsPerShareDiluted unitRef="u002" decimals="-2" contextRef="c00006">0.79</us-gaap:EarningsPerShareDiluted>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00004">880162000</us-gaap:LiabilitiesCurrent>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-3" contextRef="c00003">817828000</us-gaap:LiabilitiesCurrent>
  <!--Accrued expenses-->
  <us-gaap:AccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00004">765182000</us-gaap:AccruedLiabilities>
  <!--Accrued expenses-->
  <us-gaap:AccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00003">700636000</us-gaap:AccruedLiabilities>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-3" contextRef="c00004">5592894000</us-gaap:Assets>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-3" contextRef="c00003">5196808000</us-gaap:Assets>
  <!--Less: accumulated depreciation-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="u000" decimals="-3" contextRef="c00004">251856000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Less: accumulated depreciation-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="u000" decimals="-3" contextRef="c00003">240104000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Other current assets-->
  <us-gaap:OtherAssetsCurrent unitRef="u000" decimals="-3" contextRef="c00004">111757000</us-gaap:OtherAssetsCurrent>
  <!--Other current assets-->
  <us-gaap:OtherAssetsCurrent unitRef="u000" decimals="-3" contextRef="c00003">144250000</us-gaap:OtherAssetsCurrent>
  <!--Accounts Receivable-->
  <us-gaap:ScheduleOfAccountsAndNotesReceivableTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;2.&amp;#160;&amp;#160;&amp;#160;Accounts Receivable &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Accounts receivable, net, consists of the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;June 30, 2009&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;(Unaudited)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;March 31, 2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trade&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;392,983&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;351,697&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;94,198&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;97,747&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;487,181&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;449,444&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsAndNotesReceivableTextBlock>
  <!--Tax benefit realized from the exercise of stock options by employees-->
  <us-gaap:TaxBenefitFromStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00005">75000</us-gaap:TaxBenefitFromStockOptionsExercised>
  <!--Tax benefit realized from the exercise of stock options by employees-->
  <us-gaap:TaxBenefitFromStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00006">0</us-gaap:TaxBenefitFromStockOptionsExercised>
  <!--Basic (in shares)-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="u001" decimals="0" contextRef="c00005">302958</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Basic (in shares)-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic unitRef="u001" decimals="0" contextRef="c00006">307493</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00005">147126000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-3" contextRef="c00006">112112000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Accounts receivable, less allowance for doubtful accounts of $18,562 in June and $18,511 in March-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-3" contextRef="c00004">487181000</us-gaap:AccountsReceivableNetCurrent>
  <!--Accounts receivable, less allowance for doubtful accounts of $18,562 in June and $18,511 in March-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-3" contextRef="c00003">449444000</us-gaap:AccountsReceivableNetCurrent>
  <!--Purchase of treasury stock-->
  <us-gaap:PaymentsForRepurchaseOfCommonStock unitRef="u000" decimals="-3" contextRef="c00005">626000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <!--Purchase of treasury stock-->
  <us-gaap:PaymentsForRepurchaseOfCommonStock unitRef="u000" decimals="-3" contextRef="c00006">231185000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <!--Other assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets unitRef="u000" decimals="-3" contextRef="c00005">-3000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Other assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets unitRef="u000" decimals="-3" contextRef="c00006">49000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Other current assets-->
  <us-gaap:IncreaseDecreaseInPrepaidExpense unitRef="u000" decimals="-3" contextRef="c00005">32493000</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <!--Other current assets-->
  <us-gaap:IncreaseDecreaseInPrepaidExpense unitRef="u000" decimals="-3" contextRef="c00006">-13487000</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <!--Depreciation-->
  <us-gaap:Depreciation unitRef="u000" decimals="-3" contextRef="c00005">11240000</us-gaap:Depreciation>
  <!--Depreciation-->
  <us-gaap:Depreciation unitRef="u000" decimals="-3" contextRef="c00006">13126000</us-gaap:Depreciation>
  <!--Income before income tax expense-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="u000" decimals="-3" contextRef="c00005">332474000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <!--Income before income tax expense-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="u000" decimals="-3" contextRef="c00006">314437000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <!--Common stock, issued shares (in shares)-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00004">422356</us-gaap:CommonStockSharesIssued>
  <!--Common stock, issued shares (in shares)-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00003">422268</us-gaap:CommonStockSharesIssued>
  <!--Common stock, shares authorized (in shares)-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00004">1000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common stock, shares authorized (in shares)-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00003">1000000</us-gaap:CommonStockSharesAuthorized>
  <!--Series preferred stock, par (in dollars per share)-->
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="u002" decimals="-2" contextRef="c00004">1</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Series preferred stock, par (in dollars per share)-->
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="u002" decimals="-2" contextRef="c00003">1</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Accounts payable-->
  <us-gaap:AccountsPayable unitRef="u000" decimals="-3" contextRef="c00004">114980000</us-gaap:AccountsPayable>
  <!--Accounts payable-->
  <us-gaap:AccountsPayable unitRef="u000" decimals="-3" contextRef="c00003">117192000</us-gaap:AccountsPayable>
  <!--Document Type-->
  <dei:DocumentType contextRef="c00007">10-Q</dei:DocumentType>
  <!--Increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00005">182156000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00006">159635000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Other income-->
  <us-gaap:OtherNonoperatingIncome unitRef="u000" decimals="-3" contextRef="c00005">0</us-gaap:OtherNonoperatingIncome>
  <!--Other income-->
  <us-gaap:OtherNonoperatingIncome unitRef="u000" decimals="-3" contextRef="c00006">716000</us-gaap:OtherNonoperatingIncome>
  <!--Entity Filer Category-->
  <dei:EntityFilerCategory contextRef="c00007">Large Accelerated Filer</dei:EntityFilerCategory>
  <!--Document Period End Date-->
  <dei:DocumentPeriodEndDate contextRef="c00007">2009-06-30</dei:DocumentPeriodEndDate>
  <!--Accounts payable-->
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="u000" decimals="-3" contextRef="c00005">-2212000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <!--Accounts payable-->
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="u000" decimals="-3" contextRef="c00006">-121883000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <!--Contract revenue-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00005">47709000</us-gaap:ContractsRevenue>
  <!--Contract revenue-->
  <us-gaap:ContractsRevenue unitRef="u000" decimals="-3" contextRef="c00006">54153000</us-gaap:ContractsRevenue>
  <!--Accounts receivable, allowance for doubtful accounts-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="u000" decimals="-3" contextRef="c00004">18562000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <!--Accounts receivable, allowance for doubtful accounts-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="u000" decimals="-3" contextRef="c00003">18511000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <!--Total liabilities and stockholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-3" contextRef="c00004">5592894000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Total liabilities and stockholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-3" contextRef="c00003">5196808000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Common stock, $.10 par; shares authorized 1,000,000; issued 422,356 shares in June and 422,268 shares in March-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00004">1503423000</us-gaap:CommonStockValue>
  <!--Common stock, $.10 par; shares authorized 1,000,000; issued 422,356 shares in June and 422,268 shares in March-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-3" contextRef="c00003">1491239000</us-gaap:CommonStockValue>
  <!--Total other assets-->
  <us-gaap:AssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00004">606312000</us-gaap:AssetsNoncurrent>
  <!--Total other assets-->
  <us-gaap:AssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00003">615126000</us-gaap:AssetsNoncurrent>
  <!--Entity Public Float-->
  <dei:EntityPublicFloat unitRef="u000" decimals="0" contextRef="c00002">84609499900</dei:EntityPublicFloat>
  <!--Income Taxes-->
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;11.&amp;#160;&amp;#160;&amp;#160;Income Taxes &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company&amp;#8217;s income tax returns for fiscal years prior to 1999 in most jurisdictions and prior to 2003 in Ireland are no longer subject to review as such fiscal years are generally closed.&amp;#160;&amp;#160;Tax authorities in various jurisdictions are in the process of reviewing the Company&amp;#8217;s income tax returns for various post-1999 fiscal years, including the Internal Revenue Service (or IRS), which has recently concluded its examination of the Company&amp;#8217;s U.S. federal income tax returns for fiscal years 2002 and 2003.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In connection with that examination, in July 2007, the IRS issued a notice of proposed adjustment primarily relating to the Company&amp;#8217;s intercompany transfer pricing methodology.&amp;#160;&amp;#160;On November 5, 2007, the IRS issued a Revenue Agent Report which seeks to assess approximately $206.7 million of additional U.S. corporation income tax relating to the examination period, excluding interest and penalties.&amp;#160;&amp;#160;The Company continues to disagree with the IRS position and adjustment because it believes that it is inconsistent with applicable tax laws and the Company intends to defend its position vigorously.&amp;#160;&amp;#160;In accordance with the Company&amp;#8217;s taxpayer appeals rights, a formal written protest of the proposed adjustment has been filed with the IRS and the matter is in administrative appeals.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;While the resolution of this issue may result in tax liabilities that are greater or less than the reserves established, Management believes that the ultimate resolution will not have a material effect on the Company&amp;#8217;s financial position or liquidity.&amp;#160;&amp;#160;If the IRS prevails in a position that increases the U.S. tax liability in excess of established reserves, it is likely that the IRS could make similar claims for years subsequent to fiscal 2003 which could be material.&amp;#160;&amp;#160;At this time Management believes that it is likely that the ultimate outcome will be determined within the next 12 months and will not have a material impact on the Company&amp;#8217;s results of operations.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company&amp;#8217;s effective tax rate was 20.9% for the three-month period ended June 30, 2009, as compared to 22.7% for the same period last year.&amp;#160; The decrease resulted primarily from additional earnings in lower tax jurisdictions and the net impact of one-time discrete tax adjustments in the June 2008 quarter.&amp;#160;&amp;#160;These prior discrete adjustments related principally to stock-based compensation in prior years offset for the most part by the termination of the Company&amp;#8217;s co-promotion agreement for Azor as well as other tax matters.&amp;#160;&amp;#160;As of June 30, 2009, the Company had accrued an additional $4,190 in interest for a total of $40,044 related to the resolution of various income tax matters.&amp;#160;&amp;#160;Effective tax rates may be affected by ongoing tax audits.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <!--Net Income Per Share-->
  <frx:ScheduleOfEarningsPerShareTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;7.&amp;#160;&amp;#160;&amp;#160;Net Income Per Share &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -9pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;A reconciliation of shares used in calculating basic and diluted net income per share follows:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="top" width="34%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="top" width="19%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="top" width="34%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;June 30,&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="right" valign="bottom" width="34%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2008&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="top" width="34%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="top" width="10%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;302,958&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="top" width="9%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;307,493&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="34%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Effect of assumed conversion of employee stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;435&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;836&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="top" width="34%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="top" width="10%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 3.6pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;303,393&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 4.5pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;308,329&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Options to purchase approximately 17,736 shares of common stock at exercise prices ranging from $20.55 to $76.66 per share that were outstanding during a portion of the three-month period ended June 30, 2009 were not included in the computation of diluted net income per share because they were anti-dilutive.&amp;#160;&amp;#160;These options expire through 2019.&amp;#160;&amp;#160;Options to purchase approximately 14,951 shares of common stock at exercise prices ranging from $34.12 to $76.66 per share that were outstanding during a portion of the three-month period ended June 30, 2008 were not included in the computation of diluted net income per share because they were anti-dilutive.&amp;#160;&amp;#160;These options expire through 2018.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The above references to earnings per share are in conformity with Financial Accounting Standards Board Staff Position Emerging Issues Task Force No. 03-6-1, &amp;#8220;Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities&amp;#8221; (or FSP EITF 03-6-1).&amp;#160;&amp;#160;The Company adopted FSP EITF 03-6-1 on April 1, 2009.&amp;#160;&amp;#160;The application of FSP EITF 03-6-1 did not have an effect on the Company&amp;#8217;s earnings per share for the three months ended June 30, 2009 and 2008.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</frx:ScheduleOfEarningsPerShareTextBlock>
  <!--Marketable Securities-->
  <us-gaap:AvailableForSaleSecuritiesTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;5.&amp;#160;&amp;#160;Marketable Securities &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Available-for-sale debt securities consist of the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;June&amp;#160;30, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains in accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses in accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Current:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Variable rate demand notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;144,839&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds and notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;157,528&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,073&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;958,408&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,668&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Floating rate notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;72,261&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(&lt;font style="DISPLAY: inline"&gt;&amp;#160;718&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total current securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,333,036&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;3,741&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(&lt;font style="DISPLAY: inline"&gt;&amp;#160;718&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Noncurrent:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds and notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;130,731&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;446&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;77,994&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;421&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Auction rate notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;36,839&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Floating rate notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;301,622&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(&lt;font style="DISPLAY: inline"&gt;&amp;#160;43,247&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total noncurrent securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;547,186&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;867&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(&lt;font style="DISPLAY: inline"&gt;&amp;#160;43,247&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,880,222&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;4,608&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;(43,965&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Proceeds from the sales of available-for-sale debt securities was $447,896 for the three months ended June 30, 2009.&amp;#160;&amp;#160;Gross realized gains on those sales for the three months ended June 30, 2009 was $3,856. For purposes of determining gross realized gains and losses, the cost of the securities is based on average cost.&amp;#160;&amp;#160;Net unrealized holding losses on available-for-sale debt securities in the amount of $39,357 for the three months ended June 30, 2009 has been included in Stockholders&amp;#8217; equity:&amp;#160;&amp;#160;Accumulated other comprehensive income.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Contractual maturities of available-for-sale debt securities at June 30, 2009, are as follows:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Within one year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,333,036&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1-5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;399,158&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5-10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;96,148&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;After 10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;51,880&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;1,880,222&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Actual maturities may differ from contractual maturities because some borrowers have the right to call or prepay obligations with or without call penalties.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;br /&gt; &lt;br /&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company currently invests funds in variable rate demand notes that have major bank liquidity agreements, municipal bonds and notes, commercial paper including money market instruments, auction rate securities and bank floating rate notes.&amp;#160;&amp;#160;Certain securities are subject to a hard-put option(s) where the principal amount is contractually assured by the issuer and any resistance to the exercise of these options would be deemed as a default by the issuer.&amp;#160;&amp;#160;Such a potential default would be reflected in the issuer&amp;#8217;s respective credit rating, for which the Company maintains investment grade requirements pursuant to its corporate investment guidelines.&amp;#160;&amp;#160;While the Company believes its investments that have net unrealized losses are temporary, further declines in the value of these investments may be deemed other-than-temporary if the credit and capital markets were to continue to deteriorate in future periods. The Company does not have the intent to sell its investments and it is more likely than not that the Company will not have to sell the investments before the recovery of its cost basis.&amp;#160;&amp;#160;Therefore, the Company does not consider these investments to be other-than-temporarily impaired and will continue to monitor global market conditions to minimize the uncertainty of impairments in future periods.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
  <!--Purchase of property, plant and equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="u000" decimals="-3" contextRef="c00005">5361000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Purchase of property, plant and equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="u000" decimals="-3" contextRef="c00006">6214000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Unrealized holding gains (losses) arising during the period, net of tax-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00005">25861000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Unrealized holding gains (losses) arising during the period, net of tax-->
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00006">-561000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <!--Cost of sales-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00005">216744000</us-gaap:CostOfGoodsSold>
  <!--Cost of sales-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-3" contextRef="c00006">197340000</us-gaap:CostOfGoodsSold>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="u000" decimals="-3" contextRef="c00004">1503423000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="u000" decimals="-3" contextRef="c00003">1491239000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <!--Deferred income taxes-->
  <us-gaap:DeferredTaxAssetsNetNoncurrent unitRef="u000" decimals="-3" contextRef="c00004">100275000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <!--Deferred income taxes-->
  <us-gaap:DeferredTaxAssetsNetNoncurrent unitRef="u000" decimals="-3" contextRef="c00003">100758000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <!--Goodwill-->
  <us-gaap:Goodwill unitRef="u000" decimals="-3" contextRef="c00004">14965000</us-gaap:Goodwill>
  <!--Goodwill-->
  <us-gaap:Goodwill unitRef="u000" decimals="-3" contextRef="c00003">14965000</us-gaap:Goodwill>
  <!--Entity Current Reporting Status-->
  <dei:EntityCurrentReportingStatus contextRef="c00007">Yes</dei:EntityCurrentReportingStatus>
  <!--Accounts receivable, net-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-3" contextRef="c00005">-37737000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Accounts receivable, net-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-3" contextRef="c00006">45867000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Total stockholders' equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00004">4426429000</us-gaap:StockholdersEquity>
  <!--Total stockholders' equity-->
  <us-gaap:StockholdersEquity unitRef="u000" decimals="-3" contextRef="c00003">4114591000</us-gaap:StockholdersEquity>
  <!--Property, plant and equipment-->
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="u000" decimals="-3" contextRef="c00004">592412000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, plant and equipment-->
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="u000" decimals="-3" contextRef="c00003">586039000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Entity Well-known Seasoned Issuer-->
  <dei:EntityWellKnownSeasonedIssuer contextRef="c00007">Yes</dei:EntityWellKnownSeasonedIssuer>
  <!--Net cash used in financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-3" contextRef="c00005">-256000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net cash used in financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-3" contextRef="c00006">-230983000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Redemption of marketable securities-->
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00005">447896000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <!--Redemption of marketable securities-->
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00006">582609000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <!--Foreign currency translation gains (losses)-->
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00005">11513000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <!--Foreign currency translation gains (losses)-->
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax unitRef="u000" decimals="-3" contextRef="c00006">-361000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <!--Series preferred stock, no shares issued (in shares)-->
  <us-gaap:PreferredStockSharesIssued unitRef="u001" decimals="0" contextRef="c00004">0</us-gaap:PreferredStockSharesIssued>
  <!--Series preferred stock, no shares issued (in shares)-->
  <us-gaap:PreferredStockSharesIssued unitRef="u001" decimals="0" contextRef="c00003">0</us-gaap:PreferredStockSharesIssued>
  <!--Series preferred stock, $1.00 par; shares authorized 1,000; no shares issued or outstanding-->
  <us-gaap:PreferredStockValue unitRef="u000" decimals="-3" contextRef="c00004">42235000</us-gaap:PreferredStockValue>
  <!--Series preferred stock, $1.00 par; shares authorized 1,000; no shares issued or outstanding-->
  <us-gaap:PreferredStockValue unitRef="u000" decimals="-3" contextRef="c00003">42227000</us-gaap:PreferredStockValue>
  <!--Current Fiscal Year End Date-->
  <dei:CurrentFiscalYearEndDate contextRef="c00007">--03-31</dei:CurrentFiscalYearEndDate>
  <!--Long-Term Debt-->
  <us-gaap:LongTermDebtTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;10.&amp;#160;&amp;#160;&amp;#160;Long-Term Debt:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On December 7, 2007, the Company established a $500 million revolving credit facility for the purpose of providing additional financial liquidity for the financing of business development and corporate strategic initiatives.&amp;#160;&amp;#160;The facility can be increased up to $750 million based upon agreement with the participating lenders and expires on December 7, 2012.&amp;#160;&amp;#160;As of August 7, 2009, the Company has not drawn any funds from the available credit.&amp;#160;&amp;#160;The utilization of the revolving credit facility is subject to the adherence to certain financial covenants such as leverage and interest coverage ratios.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <!--Stock-Based Compensation-->
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;8.&amp;#160;&amp;#160;&amp;#160;Stock-Based Compensation&lt;/font&gt; &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In August 2007 the stockholders of the Company voted to adopt the 2007 Equity Incentive Plan (or the 2007 Plan) which replaces and supersedes all prior stock option plans.&amp;#160; Under the 2007 Plan, 13,950 shares were authorized to be issued to employees of the Company and its subsidiaries at prices not less than the fair market value of the common stock at the date of grant.&amp;#160;&amp;#160;The 2007 Plan provides for the granting of incentive and nonqualified stock options, restricted stock, stock appreciation rights and stock equivalent units.&amp;#160; These awards generally vest in three to five years.&amp;#160; Stock option grants may be exercisable for up to ten years from the date of issuance.&amp;#160; As of June 30, 2009, 6,212 shares were available for grant.&lt;/font&gt;&lt;/div&gt; &lt;br /&gt; &lt;br /&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Compensation expense of $11,822 ($9,558 net of tax) was recorded for the three-month period ended June 30, 2009.&amp;#160;&amp;#160;For the three-month period ended June 30, 2008, compensation expense of $10,587 ($8,817 net of tax) was recorded.&amp;#160;&amp;#160;This expense was charged to cost of sales, selling, general and administrative and research and development expense, as appropriate.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The weighted average number of diluted common shares outstanding is reduced by the treasury stock method which, in accordance with the provisions of Statement of Financial Accounting Standards No. 123(R), &amp;#8220;Share-Based Payment&amp;#8221; takes into consideration the compensation cost attributed to future services not yet recognized.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <!--Inventories-->
  <us-gaap:InventoryDisclosureTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;3.&amp;#160;&amp;#160;&amp;#160;Inventories &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Inventories, net of reserves for obsolescence, consist of the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;June 30, 2009&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;(Unaudited)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;March 31, 2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;142,287&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;126,292&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;80&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;982&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;277,465&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;266,253&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;419,832&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;393,527&lt;/font&gt;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;br /&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <!--Net proceeds from common stock options exercised by employees under stock option plans-->
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00005">295000</us-gaap:ProceedsFromStockOptionsExercised>
  <!--Net proceeds from common stock options exercised by employees under stock option plans-->
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="u000" decimals="-3" contextRef="c00006">202000</us-gaap:ProceedsFromStockOptionsExercised>
  <!--Cash equivalent investments-->
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00004">1520685000</us-gaap:CashEquivalentsAtCarryingValue>
  <!--Cash equivalent investments-->
  <us-gaap:CashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00003">1337871000</us-gaap:CashEquivalentsAtCarryingValue>
  <!--Income tax liabilities-->
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent unitRef="u000" decimals="-3" contextRef="c00004">286303000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <!--Income tax liabilities-->
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent unitRef="u000" decimals="-3" contextRef="c00003">264389000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <!--Entity Common Stock, Shares Outstanding-->
  <dei:EntityCommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00004">301676514</dei:EntityCommonStockSharesOutstanding>
  <!--Basis of Presentation-->
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;1.&amp;#160;&amp;#160;&amp;#160;Basis of Presentation:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (or GAAP) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.&amp;#160;&amp;#160;Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&amp;#160;&amp;#160;In the opinion of Management, all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation have been included and the Company has evaluated subsequent events up to the date of this filing.&amp;#160;&amp;#160;Operating results for the three-month period ended June 30, 2009 are not necessarily indicative of the results that may be expected for the year ending March 31, 2010.&amp;#160;&amp;#160;For further information refer to the consolidated financial statements and footnotes thereto incorporated by reference in the Company's Annual Report on Form 10-K for the year ended March 31, 2009.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <!--Comprehensive income-->
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="u000" decimals="-3" contextRef="c00005">300272000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Comprehensive income-->
  <us-gaap:ComprehensiveIncomeNetOfTax unitRef="u000" decimals="-3" contextRef="c00006">241998000</us-gaap:ComprehensiveIncomeNetOfTax>
  <!--Basic (in dollars per share)-->
  <us-gaap:EarningsPerShareBasic unitRef="u002" decimals="-2" contextRef="c00005">0.87</us-gaap:EarningsPerShareBasic>
  <!--Basic (in dollars per share)-->
  <us-gaap:EarningsPerShareBasic unitRef="u002" decimals="-2" contextRef="c00006">0.79</us-gaap:EarningsPerShareBasic>
  <!--Total costs and expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00005">675677000</us-gaap:CostsAndExpenses>
  <!--Total costs and expenses-->
  <us-gaap:CostsAndExpenses unitRef="u000" decimals="-3" contextRef="c00006">652407000</us-gaap:CostsAndExpenses>
  <!--Selling, general and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00005">311807000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, general and administrative-->
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="u000" decimals="-3" contextRef="c00006">342955000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Total Revenue-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00005">1008151000</us-gaap:Revenues>
  <!--Total Revenue-->
  <us-gaap:Revenues unitRef="u000" decimals="-3" contextRef="c00006">966844000</us-gaap:Revenues>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-3" contextRef="c00004">4098840000</us-gaap:AssetsCurrent>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-3" contextRef="c00003">3785954000</us-gaap:AssetsCurrent>
  <!--Income taxes-->
  <us-gaap:IncomeTaxesPaid unitRef="u000" decimals="-3" contextRef="c00005">3484000</us-gaap:IncomeTaxesPaid>
  <!--Income taxes-->
  <us-gaap:IncomeTaxesPaid unitRef="u000" decimals="-3" contextRef="c00006">14504000</us-gaap:IncomeTaxesPaid>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00003">1338905000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00000">833052000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00004">1521061000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-3" contextRef="c00001">992687000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Net cash provided by operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00005">340180000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net cash provided by operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-3" contextRef="c00006">318595000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Income taxes liabilities-->
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable unitRef="u000" decimals="-3" contextRef="c00005">21914000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <!--Income taxes liabilities-->
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable unitRef="u000" decimals="-3" contextRef="c00006">50182000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <!--Foreign currency transaction loss (gain)-->
  <us-gaap:ForeignCurrencyTransactionGainLossRealized unitRef="u000" decimals="-3" contextRef="c00005">280000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
  <!--Foreign currency transaction loss (gain)-->
  <us-gaap:ForeignCurrencyTransactionGainLossRealized unitRef="u000" decimals="-3" contextRef="c00006">-545000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
  <!--Amortization and impairments-->
  <frx:AmortizationImpairmentsAndWriteoffs unitRef="u000" decimals="-3" contextRef="c00005">8923000</frx:AmortizationImpairmentsAndWriteoffs>
  <!--Amortization and impairments-->
  <frx:AmortizationImpairmentsAndWriteoffs unitRef="u000" decimals="-3" contextRef="c00006">27179000</frx:AmortizationImpairmentsAndWriteoffs>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest unitRef="u000" decimals="-3" contextRef="c00005">12200000</us-gaap:InvestmentIncomeInterest>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterest unitRef="u000" decimals="-3" contextRef="c00006">18230000</us-gaap:InvestmentIncomeInterest>
  <!--Series preferred stock, no shares outstanding (in shares)-->
  <us-gaap:PreferredStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00004">0</us-gaap:PreferredStockSharesOutstanding>
  <!--Series preferred stock, no shares outstanding (in shares)-->
  <us-gaap:PreferredStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00003">0</us-gaap:PreferredStockSharesOutstanding>
  <!--License agreements, product rights and other intangibles, accumulated amortization-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="u000" decimals="-3" contextRef="c00004">483883000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--License agreements, product rights and other intangibles, accumulated amortization-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="u000" decimals="-3" contextRef="c00003">474960000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Total PPE-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-3" contextRef="c00004">340556000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Total PPE-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-3" contextRef="c00003">345935000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Deferred income taxes-->
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="u000" decimals="-3" contextRef="c00004">225973000</us-gaap:DeferredTaxAssetsNetCurrent>
  <!--Deferred income taxes-->
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="u000" decimals="-3" contextRef="c00003">217811000</us-gaap:DeferredTaxAssetsNetCurrent>
  <!--Inventories, net-->
  <us-gaap:InventoryNet unitRef="u000" decimals="-3" contextRef="c00004">419832000</us-gaap:InventoryNet>
  <!--Inventories, net-->
  <us-gaap:InventoryNet unitRef="u000" decimals="-3" contextRef="c00003">393527000</us-gaap:InventoryNet>
  <!--Entity Voluntary Filers-->
  <dei:EntityVoluntaryFilers contextRef="c00007">No</dei:EntityVoluntaryFilers>
  <!--Amendment Flag-->
  <dei:AmendmentFlag contextRef="c00007">false</dei:AmendmentFlag>
  <!--Subsequent Event-->
  <us-gaap:ScheduleOfSubsequentEventsTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;12.&amp;#160;&amp;#160;&amp;#160;Subsequent Event &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On August 7, 2009, the Company entered into a license agreement with Nycomed GmbH (or Nycomed) to develop and commercialize Daxas&amp;#174; (roflumilast) in the United States.&amp;#160;&amp;#160;Daxas is Nycomed&amp;#8217;s proprietary selective phosphodiesterase 4 (or PDE4) enzyme inhibitor being developed for the treatment of chronic obstructive pulmonary disease (or COPD).&amp;#160;&amp;#160;Under the terms of the agreement, the Company will make an upfront payment to Nycomed of $100,000 which will be recorded to research and development expense.&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company may be obligated to make payments to Nycomed for future development and sales milestones, and will pay royalties based on Daxas sales.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSubsequentEventsTextBlock>
  <!--Purchase of marketable securities-->
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00005">636308000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <!--Purchase of marketable securities-->
  <us-gaap:PaymentsToAcquireMarketableSecurities unitRef="u000" decimals="-3" contextRef="c00006">502398000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <!--Treasury stock, shares (in shares)-->
  <us-gaap:TreasuryStockShares unitRef="u001" decimals="0" contextRef="c00004">120680</us-gaap:TreasuryStockShares>
  <!--Treasury stock, shares (in shares)-->
  <us-gaap:TreasuryStockShares unitRef="u001" decimals="0" contextRef="c00003">120653</us-gaap:TreasuryStockShares>
  <!--Retained earnings-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-3" contextRef="c00004">6642134000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Retained earnings-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-3" contextRef="c00003">6379236000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00004">1509000</us-gaap:OtherAssetsNoncurrent>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-3" contextRef="c00003">1506000</us-gaap:OtherAssetsNoncurrent>
  <!--License agreements, product rights and other intangibles, less accumulated amortization of $483,883 in June and $474,960 in March-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="u000" decimals="-3" contextRef="c00004">489563000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--License agreements, product rights and other intangibles, less accumulated amortization of $483,883 in June and $474,960 in March-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="u000" decimals="-3" contextRef="c00003">497897000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00004">547186000</us-gaap:MarketableSecuritiesNoncurrent>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesNoncurrent unitRef="u000" decimals="-3" contextRef="c00003">449793000</us-gaap:MarketableSecuritiesNoncurrent>
  <!--Business Segment Information-->
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;9.&amp;#160;&amp;#160;&amp;#160;Business Segment Information &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company operates in only one segment.&amp;#160;&amp;#160;Below is a breakdown of net sales by therapeutic class:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="6" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;June 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2008&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td align="left" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Central nervous system&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;839,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;810,320&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td align="left" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cardiovascular&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;46,043&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;9,815&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;63,167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73,610&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;948,242&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;893,745&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <!--Effect of exchange rate changes on cash-->
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="u000" decimals="-3" contextRef="c00005">36005000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <!--Effect of exchange rate changes on cash-->
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="u000" decimals="-3" contextRef="c00006">-1974000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <!--Net cash (used in) provided by investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-3" contextRef="c00005">-193773000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net cash (used in) provided by investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-3" contextRef="c00006">73997000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Treasury stock, at cost (120,680 shares in June and 120,653 shares in March)-->
  <us-gaap:TreasuryStockValue unitRef="u000" decimals="-3" contextRef="c00004">3751592000</us-gaap:TreasuryStockValue>
  <!--Treasury stock, at cost (120,680 shares in June and 120,653 shares in March)-->
  <us-gaap:TreasuryStockValue unitRef="u000" decimals="-3" contextRef="c00003">3750966000</us-gaap:TreasuryStockValue>
  <!--License and Collaboration Agreements-->
  <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;6.&amp;#160;&amp;#160;&amp;#160;License and Collaboration Agreements &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands)&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Effective this quarter, the Company implemented Emerging Issues Task Force No. 07-1, &amp;#8220;Accounting for Collaborative Arrangements&amp;#8221; (or EITF 07-1), which prescribes that certain transactions between collaborators be recorded in the income statement on either a gross or net basis, depending on the characteristics of the collaboration relationship, and provides for enhanced disclosure of collaborative relationships.&amp;#160;&amp;#160;The Company has entered into two collaboration arrangements to develop and commercialize potential drug candidates as defined by EITF 07-1.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -4.5pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;These collaborations are contractual agreements with third parties consisting of a joint operating activity involving the research and development, manufacturing and marketing of a product.&amp;#160;&amp;#160;These collaboration agreements are profit sharing in nature and consequently both the Company and its partners are active participants and are subject to significant risks and rewards.&amp;#160;&amp;#160;These collaborative arrangements generally require the Company to make milestone and royalty payments based upon the results of specific research and development objectives and future sales, if any.&amp;#160;&amp;#160;These agreements also include provisions for reimbursement of certain expenses between the Company and its partners.&amp;#160;&amp;#160;The Company has entered into several other license agreements which are not profit sharing in nature and accordingly do not qualify as collaboration agreements as defined by the EITF.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In October 2008, the Company entered into a collaboration agreement with Phenomix Corporation (or Phenomix) to co-develop and co-promote dutogliptin.&amp;#160;&amp;#160;Dutogliptin is Phenomix&amp;#8217; proprietary orally administered, small molecule dipeptidyl-peptidase-4 (or DPP-4) inhibitor being developed for the treatment of Type II diabetes.&amp;#160;&amp;#160;The Company made a $75,000 upfront payment to Phenomix in fiscal 2009, which was recorded to research and development expense.&amp;#160;&amp;#160;The Company is responsible for the manufacture, supply and distribution of the product and will be responsible for sales in the United States, Canada, Mexico and their related territories.&amp;#160;&amp;#160;This product has not yet been approved and accordingly has not produced revenues.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -9pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In September 2007, the Company entered into a collaboration agreement with Ironwood Pharmaceuticals, Inc. (or Ironwood) to co-develop and co-market Ironwood&amp;#8217;s first-in-class compound linaclotide.&amp;#160;&amp;#160;Linaclotide is currently being investigated for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation.&amp;#160;&amp;#160;Under the terms of the agreement, the Company paid Ironwood a $70,000 upfront licensing fee in fiscal 2008 which was recorded to research and development expense.&amp;#160;&amp;#160;The Company and Ironwood will jointly and equally fund development and commercialization of linaclotide in the United States, sharing profits equally.&amp;#160;&amp;#160;Additionally, the Company will have exclusive rights in Canada and Mexico and will pay Ironwood a royalty on net sales in these countries while Ironwood retains all rights to linaclotide outside of North America.&amp;#160;&amp;#160;This product has not yet been approved and accordingly has not produced revenues.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <!--Inventories, net-->
  <us-gaap:IncreaseDecreaseInInventories unitRef="u000" decimals="-3" contextRef="c00005">-26305000</us-gaap:IncreaseDecreaseInInventories>
  <!--Inventories, net-->
  <us-gaap:IncreaseDecreaseInInventories unitRef="u000" decimals="-3" contextRef="c00006">-46063000</us-gaap:IncreaseDecreaseInInventories>
  <!--Stock-based compensation expense-->
  <us-gaap:ShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00005">11822000</us-gaap:ShareBasedCompensation>
  <!--Stock-based compensation expense-->
  <us-gaap:ShareBasedCompensation unitRef="u000" decimals="-3" contextRef="c00006">10587000</us-gaap:ShareBasedCompensation>
  <!--Income tax expense-->
  <us-gaap:IncomeTaxExpenseBenefit unitRef="u000" decimals="-3" contextRef="c00005">69576000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income tax expense-->
  <us-gaap:IncomeTaxExpenseBenefit unitRef="u000" decimals="-3" contextRef="c00006">71517000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Net sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00005">948242000</us-gaap:SalesRevenueGoodsNet>
  <!--Net sales-->
  <us-gaap:SalesRevenueGoodsNet unitRef="u000" decimals="-3" contextRef="c00006">893745000</us-gaap:SalesRevenueGoodsNet>
  <!--Common stock, par (in dollars per share)-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u002" decimals="-2" contextRef="c00004">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common stock, par (in dollars per share)-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u002" decimals="-2" contextRef="c00003">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Entity Central Index Key-->
  <dei:EntityCentralIndexKey contextRef="c00007">0000038074</dei:EntityCentralIndexKey>
  <!--Entity Registrant Name-->
  <dei:EntityRegistrantName contextRef="c00007">Forest Laboratories Inc</dei:EntityRegistrantName>
  <!--Fair Value Measurements-->
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c00005">&lt;div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;4.&amp;#160;&amp;#160;&amp;#160;Fair Value Measurements &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;(In thousands&lt;/font&gt;)&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;:&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The following table presents the level within the fair value hierarchy at which the Company&amp;#8217;s financial assets are carried at fair value and measured on a recurring basis:&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div&gt; &lt;table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt; &lt;tr&gt; &lt;td valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;Description&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -2.6pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair value at&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -2.6pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;June 30, 2009&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Quoted prices in active markets for identical assets&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;(Level 1)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="PADDING-BOTTOM: 2px"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Significant other observable market inputs&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;(Level 2)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="BORDER-BOTTOM: black 2px solid"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unobservable&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;market inputs&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="DISPLAY: inline"&gt;&amp;#160;&amp;#160;(Level 3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Money market accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,317,126&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,317,126&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td colspan="2" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="36%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Municipal bonds and notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;288,259&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;288,259&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="36%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,073,747&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;557,572&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;516,175&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="36%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Variable rate demand notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;144,839&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;144,839&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="36%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Floating rate notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;373,883&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;373,883&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td align="left" valign="bottom" width="36%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Auction rate securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;36,839&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="9%" style="TEXT-ALIGN: right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$36,839&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As of June 30, 2009, the Company has determined the value of the auction rate securities portfolio based upon a discounted cash flow model, which has been unchanged since the beginning of this fiscal period.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 1, 2009, the Company adopted the provisions of Statement of Financial Standards No. 157, &amp;#8220;Fair Value Measurements&amp;#8221; for non-financial assets and non-financial liabilities.&amp;#160;&amp;#160;This statement did not have a material effect on the Company&amp;#8217;s condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The majority of the Company&amp;#8217;s non-financial assets and liabilities are not required to be carried at fair value on a recurring basis.&amp;#160; However, the Company is required on a non-recurring basis to use fair value measurements when analyzing asset impairment as it relates to license agreements, product rights and other intangible assets and long-lived assets.&amp;#160;&amp;#160;The carrying amount of cash, accounts receivable and accounts payable and other short-term financial instruments approximate their fair value due to their short-term nature.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt;&lt;/div&gt; &lt;br /&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <!--Accrued expenses-->
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00005">64546000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <!--Accrued expenses-->
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="u000" decimals="-3" contextRef="c00006">113736000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <!--Other comprehensive income (loss)-->
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00005">37374000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <!--Other comprehensive income (loss)-->
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease unitRef="u000" decimals="-3" contextRef="c00006">-922000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <!--Net income-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00005">262898000</us-gaap:NetIncomeLoss>
  <!--Net income-->
  <us-gaap:NetIncomeLoss unitRef="u000" decimals="-3" contextRef="c00006">242920000</us-gaap:NetIncomeLoss>
  <!--Series preferred stock, shares authorized (in shares)-->
  <us-gaap:PreferredStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00004">1000</us-gaap:PreferredStockSharesAuthorized>
  <!--Series preferred stock, shares authorized (in shares)-->
  <us-gaap:PreferredStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00003">1000</us-gaap:PreferredStockSharesAuthorized>
  <!--Accumulated other comprehensive loss-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-3" contextRef="c00004">-9771000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Accumulated other comprehensive loss-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-3" contextRef="c00003">-47145000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesCurrent unitRef="u000" decimals="-3" contextRef="c00004">1333036000</us-gaap:MarketableSecuritiesCurrent>
  <!--Marketable securities-->
  <us-gaap:MarketableSecuritiesCurrent unitRef="u000" decimals="-3" contextRef="c00003">1242017000</us-gaap:MarketableSecuritiesCurrent>

</xbrl>

